Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $93,630 | 18 | 44.5% |
| Travel and Lodging | $73,618 | 54 | 35.0% |
| Unspecified | $33,698 | 4 | 16.0% |
| Honoraria | $6,600 | 1 | 3.1% |
| Food and Beverage | $2,848 | 19 | 1.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk AS | $110,600 | 38 | $0 (2018) |
| Novo Nordisk Inc | $49,701 | 38 | $0 (2019) |
| Eli Lilly and Company | $41,639 | 12 | $0 (2021) |
| CSL Behring | $7,203 | 7 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $1,250 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $6,038 | 1 | Eli Lilly and Company ($6,038) |
| 2020 | $4,988 | 1 | Eli Lilly and Company ($4,988) |
| 2019 | $35,158 | 21 | Novo Nordisk Inc ($22,619) |
| 2018 | $92,988 | 30 | Novo Nordisk AS ($75,018) |
| 2017 | $71,221 | 43 | Novo Nordisk AS ($35,583) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2021 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $6,037.50 | General |
| 10/27/2020 | Eli Lilly and Company | — | — | Cash or cash equivalent | $4,987.50 | Research |
| 12/05/2019 | Novo Nordisk Inc | Victoza (Drug) | Consulting Fee | Cash or cash equivalent | $6,715.00 | General |
| Category: Diabetes | ||||||
| 12/05/2019 | Novo Nordisk Inc | Victoza (Drug) | Travel and Lodging | In-kind items and services | $569.27 | General |
| Category: Diabetes | ||||||
| 12/05/2019 | Novo Nordisk Inc | Victoza (Drug) | Travel and Lodging | In-kind items and services | $532.00 | General |
| Category: Diabetes | ||||||
| 12/05/2019 | Novo Nordisk Inc | Victoza (Drug) | Travel and Lodging | In-kind items and services | $494.94 | General |
| Category: Diabetes | ||||||
| 12/05/2019 | Novo Nordisk Inc | Victoza (Drug) | Travel and Lodging | In-kind items and services | $200.00 | General |
| Category: Diabetes | ||||||
| 12/05/2019 | Novo Nordisk Inc | Victoza (Drug) | Travel and Lodging | In-kind items and services | $166.00 | General |
| Category: Diabetes | ||||||
| 11/03/2019 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $456.60 | General |
| 06/12/2019 | Eli Lilly and Company | — | — | Cash or cash equivalent | $10,832.00 | Research |
| 06/06/2019 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $2,890.00 | General |
| 06/06/2019 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $2,890.00 | General |
| 06/06/2019 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $600.00 | General |
| 06/06/2019 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $255.27 | General |
| 06/06/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $107.09 | General |
| 06/06/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $79.55 | General |
| 05/22/2019 | Novo Nordisk Inc | Victoza (Drug) | Consulting Fee | Cash or cash equivalent | $6,477.00 | General |
| Category: Diabetes | ||||||
| 05/22/2019 | Novo Nordisk Inc | Victoza (Drug) | Travel and Lodging | In-kind items and services | $365.80 | General |
| Category: Diabetes | ||||||
| 05/22/2019 | Novo Nordisk Inc | Victoza (Drug) | Travel and Lodging | In-kind items and services | $188.10 | General |
| Category: Diabetes | ||||||
| 05/22/2019 | Novo Nordisk Inc | Victoza (Drug) | Travel and Lodging | In-kind items and services | $54.22 | General |
| Category: Diabetes | ||||||
| 05/22/2019 | Novo Nordisk Inc | Victoza (Drug) | Travel and Lodging | In-kind items and services | $22.36 | General |
| Category: Diabetes | ||||||
| 05/22/2019 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Diabetes | ||||||
| 03/13/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 11/13/2018 | Eli Lilly and Company | — | — | Cash or cash equivalent | $8,953.00 | Research |
| 10/29/2018 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $443.48 | General |
About Dr. Robert Rizza, M.D
Dr. Robert Rizza, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942289947.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Rizza, M.D has received a total of $210,393 in payments from pharmaceutical and medical device companies, with $6,038 received in 2021. These payments were reported across 96 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($93,630).
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Rochester, MN
- Active Since 01/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1942289947
Products in Payments
- Victoza (Drug) $107,818
- Product in Development (Biological) $7,203
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Rochester
Dr. Robert Heinig, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $226,760
Dr. Zachary Freedman, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $170,046
Marjorie Ann Malbas, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $156,413
Bart Clarke, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $117,050
Robert Bingham, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $103,377
Dr. Manpreet Mundi, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $95,461